Sep 30, 2026 07:20AM
Sep 29, 2026 07:03AM
Mar 18, 2026 10:03AM
Mar 18, 2026 06:33AM
Mar 18, 2026 05:57AM
Mar 17, 2026 04:08PM
Mar 17, 2026 10:39AM Increasing unusual put option volume: ALDX BW BKLN BXSL SMCX IQ MET FEZ MVST HTGC ASO SDOW
Mar 17, 2026 08:30AM
Mar 12, 2026 09:55AM
Dec 16, 2025 03:57AM
Nov 13, 2025 07:00AM
Oct 8, 2025 12:58PM
Aug 28, 2025 07:02AM
Aug 19, 2025 07:01AM Aldeyra receives fast track status for retinitis pigmentosa drug
Aug 8, 2025 12:20PM
Jul 24, 2025 07:01AM
Jul 17, 2025 07:02AM
Jun 26, 2025 08:18AM
Jun 26, 2025 07:00AM
Jun 18, 2025 03:02PM
Jun 17, 2025 07:02AM Aldeyra Therapeutics (ALDX) Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
May 6, 2025 07:08AM
May 4, 2025 08:18AM
May 2, 2025 03:33PM
May 1, 2025 03:18PM
Apr 30, 2025 07:36AM
Apr 28, 2025 07:11AM
Apr 26, 2025 07:08AM ALDX SHAREHOLDER ALERT: BFA Law Reminds Aldeyra Therapeutics, Inc. Investors of the Continuing Securities Investigation
Apr 24, 2025 07:36AM
Apr 22, 2025 07:17AM
Apr 20, 2025 07:37AM
Apr 18, 2025 03:23PM
Apr 17, 2025 03:11PM
Apr 16, 2025 08:08AM
Apr 14, 2025 08:07AM ALDX STOCK UPDATE: Aldeyra Therapeutics, Inc. Investors are Reminded to Contact BFA Law about Pending Securities Investigation
Apr 11, 2025 03:18PM
Apr 10, 2025 07:46AM
Apr 8, 2025 07:08AM
Apr 7, 2025 05:17AM
Apr 6, 2025 11:08AM
Apr 4, 2025 03:33PM
Apr 4, 2025 02:18PM Last Night Laidlaw Published Positive Comments on Aldeyra Therapeutics (ALDX), PT $11, 'a great buying opportunity given the very limited downside and much greater upside'
Apr 4, 2025 09:34AM
Apr 4, 2025 06:42AM
Apr 3, 2025 03:18PM
Apr 3, 2025 08:01AM
Apr 3, 2025 07:56AM
Mar 17, 2025 05:18AM
Feb 5, 2025 08:24AM Aldeyra Therapeutics, Inc. (ALDX) Notice: Grabar Law Office Is Investigating Claims for Long-Term Shareholders
Dec 16, 2024 06:47AM

479,042 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All